Caplin Point Laboratories Ltd.
NSE: CAPLIPOINT | BSE: 524742
₹2,721.00
₹203.60
(8.09%)
As on 01-Sep-2026 11:49IST
Market cap
₹19,134 Cr
Revenue (TTM)
₹2,287 Cr
P/E Ratio
28.8
P/B Ratio
5.1
Div. Yield
0.2 %
Quality Score
8/10
Growth Score
7/10
Valuation Score
4/10
Momentum Score
9/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹665 Cr
-
ROE
21.7 %
-
ROCE
26.2 %
-
Industry P/E
33.94
-
EV/EBITDA
20.1
-
Debt to Equity
0
-
Book Value
₹495.4
-
EPS
₹87.5
-
Face value
2
-
Shares outstanding
76,011,696
10 Years Aggregate
CFO
₹1,981.95 Cr
EBITDA
₹3,293.63 Cr
Net Profit
₹2,658.05 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Caplin Point Lab
| 48.0 | 8.1 | 34.4 | 29.7 | 37.1 | 30.1 | 27.4 |
|
BSE Healthcare
| 18.3 | 1.1 | 9.7 | 17.8 | 22.6 | 14.1 | 12.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Caplin Point Lab
| -26.8 | 84.4 | 90.1 | -16.9 | 69.9 | 71.9 | -21.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Caplin Point Lab
|
2,721.0 | 19,134.0 | 2,287.3 | 678.1 | 31.4 | 19.7 | 28.8 | 5.1 |
| 6,929.0 | 17,426.9 | 2,432.1 | 169.6 | 8.7 | 20.8 | 102.7 | 19.3 | |
| 2,032.4 | 12,525.9 | 1,479.1 | 198.6 | 18.6 | 30.3 | 62.9 | 15.5 | |
| 1,301.2 | 17,987.4 | 3,229.7 | 666.9 | 26.6 | 18.8 | 27.9 | 4.4 | |
| 4,676.0 | 21,441.1 | 2,569.8 | 735.2 | 34.4 | 19.2 | 29.2 | 4.9 | |
| 5,791.0 | 9,562.1 | 1,432.9 | 356.9 | 30.8 | 58.2 | 26.8 | 15.5 | |
| 3,150.0 | 7,200.6 | 1,805.2 | 323.8 | 24.7 | 43.7 | 22.2 | 8.7 | |
| 897.4 | 18,581.3 | 1,682.5 | 273.5 | 21.0 | 11.1 | 62.5 | 6.9 | |
| 1,021.7 | 9,444.0 | 5,004.4 | 635.3 | 14.5 | 19.8 | 15.4 | 2.9 | |
| 804.2 | 6,433.8 | 872.6 | 198.4 | 29.7 | 17.4 | 32.4 | 5.3 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Companies with less institutional holdings
4 min read•By Jugal Harpalani
2 min read•By Jugal Harpalani
5 min read•By Rajan Gulati
About Caplin Point Lab
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic,... liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry and syrups, lyophilized vials, prefilled syringes, emulsion injection, sachets, liquid injectables, topicals, pre-filled syringes, and pre-mix bags. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India. Read more
-
Incorporated
1990
-
Chairman
C C Paarthipan
-
Managing Director
Sridhar Ganesan
-
Headquarters
Chennai, Tamil Nadu
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Caplin Point Lab
What is the current share price of Caplin Point Laboratories Ltd Today?
The share price of Caplin Point Laboratories Ltd is ₹2,721.00 (NSE) and ₹2,732.50 (BSE) as of 01-Sep-2026 11:49 IST. Caplin Point Laboratories Ltd has given a return of 37.07% in the last 3 years.
What is the current PB & PE ratio of Caplin Point Laboratories Ltd?
The P/E ratio of Caplin Point Laboratories Ltd is 28.76 times as on 31-Aug-2026, a 15 discount to its peers’ median range of 33.94 times.
The P/B ratio of Caplin Point Laboratories Ltd is 5.08 times as on 31-Aug-2026, a 0 premium to its peers’ median range of 5.08 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
28.38 |
5.52 |
2024 |
21.89 |
4.49 |
2023 |
12.04 |
2.53 |
2022 |
17.19 |
3.70 |
2021 |
12.62 |
2.79 |
What is the 52 Week High and Low of Caplin Point Laboratories Ltd?
The 52-week high and low of Caplin Point Laboratories Ltd are Rs 2,745.00 and Rs 1,500.30 as of 01-Sep-2026.
What is the market cap of Caplin Point Laboratories Ltd?
Caplin Point Laboratories Ltd has a market capitalisation of ₹ 19,134 Cr as on 31-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Caplin Point Laboratories Ltd?
Before investing in Caplin Point Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.